Graham Capital Management’s Repligen RGEN Stock Holding History

Graham Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$628K	Buy	4,602 +2,516	+121%	+$309K	0.01%	635
2026 Q1	$246K	Sell	2,086 -1,822	-47%	-$255K	0.01%	889
2025 Q4	$640K	Buy	3,908 +1,389	+55%	+$218K	0.02%	535
2025 Q3	$337K	Buy	+2,519	New	+$306K	0.01%	809
2024 Q4	–	Sell	-2,620	Closed	-$390K	–	1445
2024 Q3	$390K	Sell	2,620 -847	-24%	-$121K	0.01%	707
2024 Q2	$437K	Sell	3,467 -799	-19%	-$125K	0.01%	624
2024 Q1	$785K	Buy	4,266 +1,137	+36%	+$217K	0.01%	485
2023 Q4	$563K	Buy	+3,129	New	+$487K	0.01%	563

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Graham Capital Management's RGEN Position: Q2 2026 in Review

Graham Capital Management increased its Repligen (RGEN) stake by 121% in Q2 2026, buying an estimated $309K and bringing the position to 4,602 shares worth $628K. The position accounts for 0.01% of the portfolio, ranked #635.

Graham Capital Management first reported a position in RGEN in Q4 2023 and has held it in 8 quarters since. The position peaked at $785K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Graham Capital Management held 4,602 shares of Repligen worth $628K as of Q2 2026.
Graham Capital Management bought 2,516 Repligen shares in Q2 2026, an estimated $309K.
Repligen made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #635 holding.
Graham Capital Management first reported a position in Repligen in Q4 2023 and has held it in 8 quarters since.
Graham Capital Management's Repligen position peaked at $785K in Q1 2024.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.